KalVista Pharmaceuticals (NASDAQ:KALV) CEO Benjamin Palleiko Sells 10,940 Shares
[ad_1] KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) CEO Benjamin Palleiko sold 10,940 shares of the firm’s stock in…
[ad_1] KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) CEO Benjamin Palleiko sold 10,940 shares of the firm’s stock in…
[ad_1] Note: The following is an excerpt from this week’s Earnings Trends report. You can access the full report that contains detailed…
[ad_1] People’s Bank of China USD/CNY reference rate is due around 0115 GMT. The People’s Bank of China (PBOC), China’s…
[ad_1] As investors digested the highly-anticipated earnings report from Nvidia, CNBC’s Jim Cramer rejected the notion of a looming artificial…
[ad_1] Advanced Micro Devices (AMD) stock is in the spotlight this morning, up more than 2% in premarket trading after an…
[ad_1] To allow for equitable access to all users, SEC reserves the right to limit requests originating from undeclared automated…
[ad_1] Same-store sales at its namesake stores, once a sore spot, have crept back into positive territory after a two-year-plus…
[ad_1] The Financial Times is gated, but in brief: China’s chipmakers are seeking to triple the country’s total output of…
[ad_1] Stocks @ Night is a daily newsletter delivered after hours, giving you a first look at tomorrow and last…
[ad_1] Poor financial policies have destabilized community banking for too long with excessive regulation and insufficient relief. 2023 saw the…